Cohort Profile: Basse Health and Demographic Surveillance System, the Gambia

Overview

Journal Int J Epidemiol

Specialty Public Health

Date 2025 Mar 5

PMID 40044490

Authors

Esu S Ezeani

Sarwar Gollam

Nuredin Mohammed

Anna Roca

Jahangir Hossain

Ilias Hossain

Aji Kumba Saine

Umberto DAlessandro

Grant Mackenzie

Affiliations

Soon will be listed here.

References

Nichols E, Byass P, Chandramohan D, Clark S, Flaxman A, Jakob R . The WHO 2016 verbal autopsy instrument: An international standard suitable for automated analysis by InterVA, InSilicoVA, and Tariff 2.0. PLoS Med. 2018; 15(1):e1002486. PMC: 5761828. DOI: 10.1371/journal.pmed.1002486. View

Buchwald A, Verani J, Keita A, Hossain M, Roose A, Sow S . Etiology, Presentation, and Risk Factors for Diarrheal Syndromes in 3 Sub-Saharan African Countries After the Introduction of Rotavirus Vaccines From the Vaccine Impact on Diarrhea in Africa (VIDA) Study. Clin Infect Dis. 2023; 76(76 Suppl 1):S12-S22. PMC: 10116565. DOI: 10.1093/cid/ciad022. View

Mackenzie G, Plumb I, Sambou S, Saha D, Uchendu U, Akinsola B . Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system. PLoS Med. 2012; 9(1):e1001161. PMC: 3260317. DOI: 10.1371/journal.pmed.1001161. View

Mackenzie G, Ceesay S, Hill P, Walther M, Bojang K, Satoguina J . A decline in the incidence of invasive non-typhoidal Salmonella infection in The Gambia temporally associated with a decline in malaria infection. PLoS One. 2010; 5(5):e10568. PMC: 2867957. DOI: 10.1371/journal.pone.0010568. View

Dabira E, Soumare H, Conteh B, Ceesay F, Ndiath M, Bradley J . Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia. Lancet Infect Dis. 2021; 22(4):519-528. DOI: 10.1016/S1473-3099(21)00557-0. View

Mackenzie G, Osei I, Salaudeen R, Secka O, DAlessandro U, Clarke E . Pneumococcal conjugate vaccination schedules in infants-acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study. Trials. 2022; 23(1):39. PMC: 8760872. DOI: 10.1186/s13063-021-05949-4. View

Mackenzie G, Hill P, Jeffries D, Hossain I, Uchendu U, Ameh D . Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study. Lancet Infect Dis. 2016; 16(6):703-711. PMC: 4909992. DOI: 10.1016/S1473-3099(16)00054-2. View

Howie S, Bottomley C, Chimah O, Ideh R, Ebruke B, Okomo U . Zinc as an adjunct therapy in the management of severe pneumonia among Gambian children: randomized controlled trial. J Glob Health. 2018; 8(1):010418. PMC: 5908397. DOI: 10.7189/jogh.08.010418. View

Hossain M, Roca A, Mackenzie G, Jasseh M, Hossain M, Muhammad S . Serogroup W135 meningococcal disease, The Gambia, 2012. Emerg Infect Dis. 2013; 19(9):1507-10. PMC: 3810914. DOI: 10.3201/eid1909.130077. View

10.

Oduro A, Conway D, Schellenberg D, Satoguina J, Greenwood B, Bojang K . Seroepidemiological and parasitological evaluation of the heterogeneity of malaria infection in the Gambia. Malar J. 2013; 12:222. PMC: 3701490. DOI: 10.1186/1475-2875-12-222. View

11.

Bojang K, Akor F, Conteh L, Webb E, Bittaye O, Conway D . Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial. PLoS Med. 2011; 8(2):e1000409. PMC: 3032548. DOI: 10.1371/journal.pmed.1000409. View

12.

De Francisco A, Schellenberg J, Hall A, Greenwood A, Cham K, Greenwood B . Comparison of mortality between villages with and without Primary Health Care workers in Upper River Division, The Gambia. J Trop Med Hyg. 1994; 97(2):69-74. View

13.

. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet. 2019; 394(10200):757-779. PMC: 6727070. DOI: 10.1016/S0140-6736(19)30721-4. View

14.

Chhibber A, Hill P, Jafali J, Jasseh M, Hossain M, Ndiaye M . Child Mortality after Discharge from a Health Facility following Suspected Pneumonia, Meningitis or Septicaemia in Rural Gambia: A Cohort Study. PLoS One. 2015; 10(9):e0137095. PMC: 4564213. DOI: 10.1371/journal.pone.0137095. View

15.

Sow S, Okoko B, Diallo A, Viviani S, Borrow R, Carlone G . Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. N Engl J Med. 2011; 364(24):2293-304. DOI: 10.1056/NEJMoa1003812. View

16.

Mackenzie G, McLellan J, Machuka E, Ndiaye M, Pathirana J, Fombah A . Aetiology of lobar pneumonia determined by multiplex molecular analyses of lung and pleural aspirate specimens in the Gambia: findings from population-based pneumonia surveillance. BMJ Open. 2022; 12(3):e056706. PMC: 8915295. DOI: 10.1136/bmjopen-2021-056706. View

17.

Satoguina J, Walther B, Drakeley C, Nwakanma D, Oriero E, Correa S . Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia and Guinea Bissau. Malar J. 2009; 8:274. PMC: 2791766. DOI: 10.1186/1475-2875-8-274. View

18.

Kotloff K, Nataro J, Blackwelder W, Nasrin D, Farag T, Panchalingam S . Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013; 382(9888):209-22. DOI: 10.1016/S0140-6736(13)60844-2. View

19.

DAlessandro U, Olaleye B, McGuire W, Langerock P, Bennett S, Aikins M . Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet. 1995; 345(8948):479-83. DOI: 10.1016/s0140-6736(95)90582-0. View

20.

Mackenzie G, Hill P, Jeffries D, Ndiaye M, Sahito S, Hossain I . Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance. Lancet Infect Dis. 2021; 21(9):1293-1302. PMC: 8384632. DOI: 10.1016/S1473-3099(20)30880-X. View